# Omega-3 Fatty Acids for Treating Adults With Major Depression

> **NCT00517036** · PHASE3 · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 196 (actual)

## Conditions studied

- Depression

## Interventions

- **DIETARY_SUPPLEMENT:** EPA omega-3 fatty acid
- **DIETARY_SUPPLEMENT:** DHA omega-3 fatty acid
- **DIETARY_SUPPLEMENT:** Placebo comparator

## Key facts

- **NCT ID:** NCT00517036
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2013-04-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00517036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00517036, "Omega-3 Fatty Acids for Treating Adults With Major Depression". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00517036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*